About
Race Oncology Ltd (AU:RAC) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 31 2026
First Patient Recruited to HARNESS-1 Lung Cancer Trial
Mar 19 2026
First Patient Dosed Safely with RC220 in Hong Kong
Mar 16 2026
Racura HARNESS-1 Trial Receives Governance Approval
Feb 27 2026
Appendix 4D & Half-Year Financial Statements
Feb 11 2026
Racura Develops Novel Cardioprotection Blood Test
Financials
Revenue
A$3.48 M
Market Cap
A$478.58 M
EPS
-0.05
Translate